PCR and real-time PCR testing market seen reaching $16.38B by 2030

The PCR and real-time PCR testing market is projected to grow from $11.12 billion in 2025 to $16.38 billion by 2030, driven by personalized medicine, digital PCR adoption and broader use in clinical diagnostics. Asia-Pacific was the largest regional market in 2025 and is expected to grow fastest.

Why it matters: - PCR and real-time PCR testing sit at the center of molecular diagnostics, supporting disease detection, research and personalized medicine. - The market’s projected rise signals continued demand for faster, more precise testing in clinical and research settings. - Growth in this market also reflects broader spending on life sciences research and decentralized diagnostics.

What happened: - The PCR and real-time PCR testing market is projected to rise from $11.12 billion in 2025 to $12.02 billion in 2026. - The market is forecast to reach $16.38 billion by 2030, implying an 8.0% CAGR over the period. - The Business Research Company released the forecast on Aug. 21, 2026. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the PCR and real-time PCR testing market report. - View the full PCR and real-time PCR testing market report.

The details: - Recent growth has come from broader adoption of molecular diagnostic techniques. - Rising infectious disease incidence has added to testing demand. - Genomics research activity has expanded the market’s use cases. - Clinical diagnostics have become a larger end market for PCR tools. - Academic research facilities have continued to adopt PCR platforms. - Future growth is expected to come from personalized medicine, digital PCR uptake, decentralized diagnostic testing, life sciences investment, oncology applications and genetic testing. - Emerging trends include high-throughput PCR platforms, multiplex real-time PCR assays, automated sample preparation systems, broader digital PCR applications and a stronger focus on contamination-free testing. - PCR and real-time PCR detect and quantify DNA or RNA in biological samples. - Automated thermal cyclers reduce the risk of cross-contamination. - The technologies are used for cloning, genotyping, mutation analysis, paternity testing, sequencing and microarray studies. - In 2025, Asia-Pacific was the largest regional market. - Western Europe was the second-largest regional market in 2025. - Asia-Pacific is expected to grow fastest, supported by healthcare infrastructure development and rising demand for advanced diagnostic testing.

Between the lines: - The market’s growth is closely tied to personalized medicine, where genetic profiling drives treatment decisions. - Regulatory approvals for personalized therapies are likely to keep supporting testing demand. - The February 2024 FDA approvals cited in the release show how faster personalized-medicine adoption can translate into more demand for PCR-based diagnostics. - The shift toward decentralized testing suggests more PCR use outside centralized labs. - Digital PCR and automation point to a market moving toward higher throughput and more standardized workflows.

What's next: - The market is expected to keep expanding through 2030 as PCR use broadens in oncology, genetic testing and routine diagnostics. - Asia-Pacific is positioned to lead future growth as healthcare systems add advanced diagnostic capacity. - Companies in the space will likely focus on automation, multiplexing and contamination control to differentiate platforms.

The bottom line: - PCR and real-time PCR testing remain a core diagnostics growth market, with steady demand and a clear path to $16.38 billion by 2030.